Photoactivatable Prodrugs
Photoactivatable Prodrugs - Related Videos
01:30
Prodrugs
0 Views •
2023
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration. Prodrugs help overcome...
04:54
Evaluation of Controlled T Cell Activation with a Photoactivatable Peptide MHC
0 Views •
2025
This video demonstrates a method of decaging a photoactivatable peptide-major histocompatibility complex using UV irradiation. The decaging process exposes the native peptide sequence, enabling precise T cell activation.
07:55
Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
0 Views •
Cited by 6 •
2015
While the transport of cell surface proteins is relatively easily studied, visualizing the trafficking of intracellular proteins is much more difficult. Here, we use constructs incorporating photoactivatable GFP and demonstrate a method to accurately follow the amyloid precursor protein from the Golgi apparatus to down-stream compartments and follow its clearance.
08:54
Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
0 Views •
2023
This protocol describes the fabrication and characterization of a photoresponsive prodrug-dye nanoassembly. The methodology for drug release from the nanoparticles by light-triggered disassembly, including the light irradiation setup, is explicitly described. The drugs released from the nanoparticles following light irradiation exhibited excellent anti-proliferation effects on human colorectal tumor cells.
07:48
Spatial and Temporal Control of T Cell Activation Using a Photoactivatable Agonist
0 Views •
Cited by 5 •
2018
This protocol describes an imaging-based method to activate T lymphocytes using photoactivatable peptide-MHC, enabling precise spatiotemporal control of T cell activation.
FAQs
The key chemical event is photochemical cleavage or structural rearrangement of a light-sensitive protecting group. This change converts the less active or inactive precursor into a pharmacologically active drug. Because activation depends on illumination rather than only on distribution through the body, the design can connect drug release to a selected exposure event in medicine.
Wavelength, intensity, and exposure duration determine how effectively illumination triggers the prodrug’s photochemical transformation. Changing these parameters can alter when and where the active compound appears, so they are central experimental variables. Researchers must relate the selected light conditions to the intended treatment site and the desired control over drug timing.
Conventional administration does not use illumination as the main trigger for revealing drug activity at a chosen location. Photoactivatable Prodrugs instead provide an external timing and localization control: illuminated tissue can receive the active form while limiting activity elsewhere. This approach may reduce off-target effects, although its usefulness depends on effective light delivery and activation.
Tissue penetration, delivery, and safe activation are major limitations identified for living systems. Light must reach the intended tissue sufficiently to trigger the chemical conversion, while the prodrug must be delivered to an appropriate site. Research therefore focuses on balancing access to the target with controlled activation that does not create unwanted effects.
A basic investigation links prodrug design with controlled illumination and evaluation of the resulting drug activity. Researchers select light conditions, expose the relevant system or tissue, and assess whether activation occurs at the intended time and location. The outcome can reveal how wavelength, intensity, and exposure duration influence localized treatment control.
In cancer research, localized illumination can help direct drug action toward illuminated tumor tissue. Antimicrobial studies use the same general strategy to investigate light-controlled treatment at selected sites. These applications are intended to improve spatial control and potentially limit activity outside the treated region, while delivery and tissue penetration remain important research considerations.
Experimental photopharmacology uses light as a controllable input for investigating when and where a drug becomes active. Photoactivatable Prodrugs support this approach by linking photochemical activation to pharmacological effects. Studies can therefore examine dose timing and localized action under defined illumination, while also addressing how safely the strategy can operate in living systems.